Robuta

https://www.biospace.com/theregen-launches-second-phase-i-study-of-anginera-cell-based-patch-in-heart-patients
phase i studylaunchessecondcellbased
https://pubmed.ncbi.nlm.nih.gov/32816889/
phase i studycadherintargetedradioimmunotherapy
https://www.academia.edu/143847770/Phase_I_Study_of_Entinostat_Atezolizumab_Carboplatin_and_Etoposide_in_Previously_Untreated_Extensive_Stage_Small_Cell_Lung_Cancer_ETCTN_10399
Background CREBBP and EP300 mutations occur at a frequency of 15% and 13%, respectively, in small cell lung cancer (SCLC), and preclinical models demonstrated...
phase i studypdfentinostatatezolizumabcarboplatin
https://www.mskcc.org/cancer-care/clinical-trials/22-045
Full Title An Open-label, Multi-center, Non-randomized Phase I Dose Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary...
phase i studyonoimmunotherapypeople
https://www.news-medical.net/news/20100923/Athersys-presents-MultiStem-phase-I-study-results-at-TCT-Conference.aspx
Athersys, Inc. announced at its presentation at the Transvascular Cardiovascular Therapeutics (TCT) Conference held in Washington, D.C., updated results from...
phase i studypresentsresultstctconference
https://www.biospace.com/alnylam-pharmaceuticals-initiates-phase-i-clinical-study-for-aln-ttrsc-a-subcutaneously-administered-rnai-therapeutic-targeting-transthyretin-ttr-f
alnylam pharmaceuticalsclinical studyinitiatesphase